Roche to invest $50 billion in U.S. as pharma tariff threat lingers

Svizzed Pharmaceutics Rock on tuesday she said That would invite 50 billion us in the next five years, looking for the impact of the possible white fees on the pharma goods from the outside.

The investment has to create 1200 work, rod, rodness – 1000 with the company, and the rest to support nine manufacturing of the US manufacture. The firm said already hiring more than 25,000 people in America.

ROC-Action were 1.1% lower than 8:39 AM in London.

Pussy Figures will inject money in charge of research and development of the State (R & D), while running the inspange to the facility, Pennessette and California. A new R & D site in Massachusetts will be used for the search AI and act as Hub for searching in charge of cardiovascular, renal dealings and metabolism.

The funding package will also be used to build a new 900,000 manufacturing center in an unknown place to support the routes of the next loss generation of wishes of feet. ‘

Once the ability to ability capability capability capability capability capability tells that expiring more medicine products from the USA of import.

Pharmaceutic companies have been scrambling for bolster its USA of AMID threat by Donald Trump President to complete the exemption of industry by import fees.

“We’re going to announce a lot of a large fee on pharmaceutics”, he he said before this month. I am

Row investment follows similar moves from important rivals. First this month, Swiss Novare announced Plans to invent 11 billion 20 billion and expansion of 10 US strip, in a move said to create more than 4,000 jobs.

Gates astrazheneca last moth she said that approached $ 2.5 billion in creation of a hub Beijing. However, Ceya Pascal Soriot company, also the astrazene, “very imputed to the US”, they have two-scheduled focuses and very large development.

CEO WOME SCHINECECHER SENDING IN A DEVESTUMENT OF INVESTUMENT OF THE MONIONAL COMPANY CHARGE AND FACE AND FACE AND FACE

“We’re proud of the 110 yr salumacy that has been a named Today, Innovation, innovation of the inteltual property in the United States, through our Pharmaceutic Divisions,” he said. “Our 50 billion investments for the next years for our next was of the innovation and growth of profit and around the Chinese.”